Table 4. Trials of Clinical Breast Examination and Breast Self Examination.
Author, Year (reference) | Technique | Years | Setting/Population (no. screening; no. control) | Ages at Enrollment (years) | Study Design | Intervention | Primary Outcomes | Secondary Outcomes | USPSTF Quality Rating |
---|---|---|---|---|---|---|---|---|---|
Pisani et al, 2006 (53) | CBE | 1996-1997 | Manila, Philippines; women living in the 12 central areas (151,168; controls not indicated) | 35-64 | RCT; block randomization of 202 health centers | 5 annual CBEs vs usual care provided by nurses and midwives; CBE instruction using the MAMMACARE program | Breast cancer mortality not reported |
*False negative: 80/133 diagnosed breast cancers *False positive: 1182/1220 (96.9%) of those who completed follow-up |
Poor: low participation; discontinued after one round |
Boulos et al, 2005 (54) | CBE/BSE | Pilot: 2000-2002 RCT: ongoing | Cairo, Egypt; women living in area around Italian Hospital (screening phase 1= 4,116 with 1,924 at early follow-up; controls late follow-up 1,927) | Phase 1: 35-64 Phase 2 and 3: 39-65 | Phase 1: cohort Phase 2: RCT; block randomization | CBE/BSE× (intervention) vs CBE/BSE× (control) provided by female physicians; CBE training at Italian Hospital 2 months prior to study | Breast cancer incidence | Benign procedures: 1.2% after one round | Not rated (in progress) |
Trial in progress (55) | CBE/BSE | 1998 and ongoing | Mumbai, India; women living in area around Tata Memorial Hospital (150,000; controls not indicated) | 35-64 | RCT; cluster randomization | CBE + BSE + breast health education every 24 months for 4 rounds vs education alone provided by trained female health workers; CBE training for 5 months prior to trial | Breast cancer mortality | Not available | Not rated (in progress) |
Thomas et al, 2002 (58) | BSE | 1989-2000 | Shanghai, China; women working at one of 519 factories (132,979; 133,085) | 31-65 | RCT; factories assigned to BSE or control group | BSE instruction with periodic reinforcement provided by trained former factory medical workers vs no instruction; initial BSE instruction, follow-up sessions at 1 and 3 years, medical supervised BSE every 6 months | Breast cancer mortality: RR 1.03 (95% CI 0.81-1.31) | Benign biopsies: RR 1.57 (95% CI 1.48-1.68) | Good |
Semiglazov et al, 2003 (18) | BSE | 1985-2001 | St. Petersburg, Russia; women attending one of 28 clinics (58,985; 64,763) | 40-64 | RCT; cluster randomization | BSE instruction with refresher every 3 years provided by trained nurses or physicians vs no instruction; providers received 3-hour training; instruction given to groups of 5 to 20 women | All cause mortality: RR 1.07 (95% CI 0.88-1.29) | Benign biopsies: RR 2.05 (95% CI 1.80-2.33) | Fair: low adherence; inconsistent data reported |
Risks not calculated because diagnostic follow-up for a positive CBE was 35%
Abbreviations: BSE = breast self examination; CBE = clinical breast examination; RCT = randomized controlled trial; RR = relative risk; CI = confidence interval.